|
1
|
Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, Bixby H, Cowan MJ, Ali MK, Taddei C, et al: NCD Risk Factor Collaboration (NCD-RisC): Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 387:1513–1530. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mann JF, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B and Buse JB: LEADER Steering Committee and Investigators. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med. 377:839–848. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D and Mogensen CE: Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int. 87:20–30. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Haas M, Spargo BH, Wit EJ and Meehan SM: Etiologies and outcome of acute renal insufficiency in older adults: A renal biopsy study of 259 cases. Am J Kidney Dis. 35:433–447. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Farrington K, Levison DA, Greenwood RN, Cattell WR and Baker LR: Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med. 70:221–233. 1989.PubMed/NCBI
|
|
6
|
Perazella MA and Markowitz GS: Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 6:461–470. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Praga M and González E: Acute interstitial nephritis. Kidney Int. 77:956–961. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E and Donohoe J: Acute interstitial nephritis: Clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 19:2778–2783. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, et al: Grupo Madrileño De Nefritis Intersticiales: Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 73:940–946. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shinzato T, Ohara K, Kaminaga H, Sugase T, Masuda T, Nagata D, Saki K, Kinoshita Y, Kubo T, Shimizu T, et al: Acute interstitial nephritis and acute tubular injury due to a transdermal loxoprofen patch. Intern Med. 59:2733–2736. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moledina DG and Perazella MA: Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 12:2046–2049. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, et al: American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology: Cardiorenal Syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation. 139:e840–e878. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kalra S, Aydin H, Sahay M, Ghosh S, Ruder S, Tiwaskar M, Kilov G, Kishor K, Nair T, Makkar V, et al: Cardiorenal syndrome in type 2 diabetes mellitus - rational use of sodium-glucose cotransporter-2 inhibitors. Eur Endocrinol. 16:113–121. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Raghavan R and Eknoyan G: Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 82:149–162. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Neilson EG: Mechanisms of disease: Fibroblasts--a new look at an old problem. Nat Clin Pract Nephrol. 2:101–108. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J and Dragoi S: Rationale and strategies for preserving residual kidney function in dialysis patients. Am J Nephrol. 50:411–421. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW and Krediet RT: NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 41:1293–1302. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bargman JM, Thorpe KE and Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 12:2158–2162. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, Chen J, Mathew AT, Kovesdy CP, Mehrotra R, et al: Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study. Am J Kidney Dis. 68:256–265. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR and Coresh J: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 56:348–358. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kritmetapak K, Anutrakulchai S, Pongchaiyakul C and Puapairoj A: Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients. Clin Kidney J. 11:342–347. 2018.PubMed/NCBI View Article : Google Scholar
|
